WELCOME TO THE NAEF K. BASILE CANCER
INSTITUTE
The Naef K. Basile Cancer Institute (NKBCI) at the American University of Beirut Medical Center (AUBMC) is a state-of-the-art adult cancer facility providing comprehensive cancer treatment and research.
The Institute was established through the generous contribution of the Naef K. Basile Foundation. The late Lebanese-American physician’s lifelong wish was to give back to his country of birth, founding an institute that would compare with the best cancer centers in the world.
The NKBCI relies on multidisciplinary specialized teams to diagnose and treat cancer and fosters health education programs to raise awareness on cancer prevention and early diagnosis.
THE NEW GENOMIC PROFILING PROGRAM
The newly established GENOMIC PROFILING PROGRAM welcomes patients, opening the door to Precision Medicine, a new era in medical care.
Consult with your NKBCI Hematology-Oncology physician for recommended referrals.
Consult the Genomic Profiling Program for more info.
CANCER PREVENTION AND CONTROL PROGRAM ACTIVITIES
Check what cancer awareness activities The Naef K. Basile Institute and its Cancer Prevention and Control Program have been up to at the link below !
Cancer Prevention and Control Program activities
UPDATED! SKIN CANCER INFORMATION
Newly published information on preventing Skin Cancer & detecting dangerous moles, a guide on Lung Cancer in English and Arabic and more on Healthy Living and Cancer Prevention, Dealing With Cancer, Tobacco & Cancer at our Information Resources page
SCHEDULE AN ONLINE CONSULTATION
Request an online apointment with a Hematology Oncology Specialist or learn how to schedule one through MyAUBHealth.
You can also contact the call center directly on 01- 759 618.
MESSAGE FROM THE DIRECTOR
The NKBCI is an exciting and growing institute with leading clinicians, educators, and scientists working together to improve patient care. Our faculty participates in a full-range of academic activities that includes basic science research, clinical research, and teaching. We aspire to be a reference in medical care, leading innovation in the treatment of cancer in Lebanon and the region.
Ali Taher, MD, Ph.D., FRCP